Grippostad C hard capsules

Grippostad C is one of Germany's most recognizable and widely used over-the-counter (OTC) medications for the symptomatic treatment of common cold and flu symptoms. The brand was developed by STADA Arzneimittel AG, a company with deep roots in the German pharmaceutical industry dating back to 1895. The capsule formulation is known for its combination of paracetamol, caffeine, chlorphenamine maleate, and ascorbic acid (Vitamin C), designed to target aches, rhinitis, and fever simultaneously.

While the brand is quintessentially German in its origin and primary manufacturing, its ownership has transitioned to international private equity. STADA, the parent company, underwent a major acquisition in 2017 and is now primarily controlled by Bain Capital and Cinven. Despite this shift in top-level ownership, the brand maintains its headquarters and significant production facilities in Bad Vilbel, Germany, ensuring the legacy of German engineering and pharmaceutical standards remains central to the brand's identity.